EUVIMEDEUVIMED entdecken
Open Access

Drugless peptide-based nanohybrids alleviate diabetic retinopathy by suppressing microglial activation and endothelial inflammation

Mei Du, Xiao Zhao, Miao Guo, Xiaoyu Wang, Yutian Zhang, Linshan Yang, Sixia Liu, Liya Sun, Mengyu Liao, Xue Dong, Yi Lei, Yumeng Zhao und 5 weitere

Theranostics · 03.03.2025 · 15 (9) · 3943-3960

DOI: 10.7150/thno.102775 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Theranostics, erschienen am 03.03.2025. Verfasst von Mei Du und 16 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Molecular Ophthalmology, Tianjin Medical University, Tianjin 300070, China. Hauptthemen laut MEDLINE: Diabetic Retinopathy, Microglia, Anti-Inflammatory Agents, Peptides. Die Arbeit wurde bisher 17-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic RetinopathyMicrogliaAnti-Inflammatory AgentsPeptidesAnimalsMiceHumansDiabetes Mellitus, ExperimentalHuman Umbilical Vein Endothelial CellsInflammationDisease Models, AnimalMice, Inbred C57BLGoldMaleEndothelial CellsCell LineMetal NanoparticlesRetina

Stichwörter der Autor:innen

Toll-like receptorsbioactive nanoparticlesdiabetic retinopathyendothelial inflammationmicroglia activation

Substanzen

Anti-Inflammatory AgentsPeptidesGold

Autor:innen und Institutionen

  • Laboratory of Molecular Ophthalmology, Tianjin Medical University, Tianjin 300070, China.
  • Department of Ophthalmology, Tianjin Medical University General Hospital, Ministry of Education International Joint Laboratory of Ocular Diseases, China-UK "Belt and Road" Ophthalmology Joint Laboratory, Tianjin Key Lab…
  • Tianjin Key Laboratory of Inflammatory Biology, Department of Pharmacology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
  • The Province and Ministry Co-Sponsored Collaborative Innovation Center for Medical Epigenetics, Intensive Care Unit of the Second Hospital, Tianjin Medical University Tianjin, China.

Zitieren

APA

Du, M., Zhao, X., Guo, M., Wang, X., Zhang, Y., Yang, L., Liu, S., Sun, L., Liao, M., Dong, X., Lei, Y., Zhao, Y., Liang, S., Wang, X., You, C., Yang, H., & Yan, H. (2025). Drugless peptide-based nanohybrids alleviate diabetic retinopathy by suppressing microglial activation and endothelial inflammation. Theranostics, 15(9), 3943-3960. https://doi.org/10.7150/thno.102775

Vancouver

Du M, Zhao X, Guo M, Wang X, Zhang Y, Yang L, et al. Drugless peptide-based nanohybrids alleviate diabetic retinopathy by suppressing microglial activation and endothelial inflammation. Theranostics. 2025;15(9):3943-3960. doi:10.7150/thno.102775

BibTeX
@article{Du2025,
  author = {Du, Mei and Zhao, Xiao and Guo, Miao and Wang, Xiaoyu and Zhang, Yutian and Yang, Linshan and Liu, Sixia and Sun, Liya and Liao, Mengyu and Dong, Xue and Lei, Yi and Zhao, Yumeng and Liang, Shuqi and Wang, Xiaohong and You, Caiyun and Yang, Hong and Yan, Hua},
  title = {Drugless peptide-based nanohybrids alleviate diabetic retinopathy by suppressing microglial activation and endothelial inflammation},
  journal = {Theranostics},
  year = {2025},
  volume = {15},
  number = {9},
  pages = {3943--3960},
  doi = {10.7150/thno.102775}
}
Kostenlos starten →